FDA Label for Ranitidine Hydrochloride
View Indications, Usage & Precautions
Ranitidine Hydrochloride Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
PRINCIPAL DISPLAY PANEL - 2 mL Vial Container Label
NDC 65841-763-02
Ranitidine Injection, USP
50 mg/2 mL (25 mg/mL)*
For IV or IM Injection, or IV Infusion
2 mL Single-Use Vial
Sterile
Rx only
Zydus Pharmaceuticals
PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton Label
NDC 65841-763-02
Ranitidine Injection, USP
50 mg/2 mL (25 mg/mL)*
For IV or IM Injection, or IV Infusion
10 X 2 mL Single-Use Vials
Rx only
Sterile
Zydus Pharmaceuticals
PRINCIPAL DISPLAY PANEL - 6 mL Vial Container Label
NDC 65841-764-06
Ranitidine Injection, USP
150 mg/6 mL (25 mg/mL)*
For IV or IM Injection, or IV Infusion
6 mL Multi-Dose Vial
Sterile
Rx only
Zydus Pharmaceuticals
PRINCIPAL DISPLAY PANEL - 6 mL Vial Carton Label
NDC 65841-764-06
Ranitidine Injection, USP
150 mg/6 mL (25 mg/mL)*
For IV or IM Injection, or IV Infusion
6 mL Multi-Dose Vial
Sterile
Rx only
Zydus Pharmaceuticals
* Please review the disclaimer below.